Abstract
Conclusion
By the methods used, there was no evidence that the agglutination of B-proteus OX19 antigen would be of value in determining the presence of cancer.
Get full access to this article
View all access options for this article.
You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Select search scope: search across all journals or within the current journal
By the methods used, there was no evidence that the agglutination of B-proteus OX19 antigen would be of value in determining the presence of cancer.
View all access options for this article.